ArticleJACC. Case reports2026
Modified Ozone-Mediated Neurolysis for Resistant Hypertension in a Patient With Bilateral Renal Artery Stenosis.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCatheter-based renal denervation (RDN) has been proven to be an effective treatment for resistant hypertension (RH). However, patients with concomitant renal artery stenosis are considered contraindicated. CASE SUMMARY: A 75-year-old woman with bilateral renal artery stenosis and RH unresponsive to 5 antihypertensives combined with intravenous high-dose nitroprusside, underwent computed tomography-guided percutaneous ozone injection around the left lumbar sympathetic ganglion at the left renal artery level. The procedure led to immediate discontinuation of intravenous antihypertensives and sustained blood pressure reduction for up to 6 months. DISCUSSION: This novel approach avoids intravascular procedures and contrast agents and achieved outcomes comparable to RDN for the patient. NOVELTY: Ozone-mediated neurolysis, a traditional pain-relief technique, can be modified to produce blood pressure-lowering effects comparable to RDN. TAKE-HOME MESSAGE: Computed tomography-guided ozone-mediated neurolysis may be a promising option for RH associated with renal artery stenosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.